Casp3 is a major effector caspase activated by initiator caspases and cleaves many substrates during the execution phase of apoptosis. Mouse and mammalian evidence consistently support Casp3 as a cysteine-aspartate protease that becomes active after proteolytic processing, forms an active heterotetramer, and drives hallmark apoptotic events including substrate cleavage and apoptotic DNA fragmentation [file:mouse/Casp3/Casp3-uniprot.txt; PMID:9512515; PMID:16469926].
Much of Casp3 biology in mouse centers on developmental and stress-induced apoptosis, especially in neurons and other differentiating tissues. Casp3-deficient neurons show delayed apoptosis and reduced TUNEL staining after p53 induction, and developmental studies place Casp3 downstream of Bcl-xL in postmitotic neuronal death while also affecting neuronal progenitor apoptosis [PMID:10479688; PMID:10618441]. Additional mouse work supports a role in apoptosis triggered by ER stress and other cell-death stimuli, but many stimulus-specific or disease-specific downstream phenotypes are context dependent rather than core gene functions PMID:12847083.
Mouse experiments also support a non-lethal neuronal remodeling role. Caspase-3 activity can act locally in dendrites to regulate spine density and dendrite morphology without causing cell death, and Casp3 knockout mice show increased spine density in vivo PMID:24478350. This supports specialized neuronal remodeling annotations, but these should generally be treated as non-core relative to the canonical apoptotic effector role.
Casp3 is a major effector caspase activated by initiator caspases and cleaves many substrates during the execution phase of apoptosis. The UniProt record describes Casp3 as a thiol protease activated by CASP8, CASP9, and/or CASP10 that cleaves many apoptotic substrates including PARP1 and other caspases [file:mouse/Casp3/Casp3-uniprot.txt].
The active enzyme is a heterotetramer composed of p17 and p12 subunits and is primarily cytoplasmic or cytosolic before context-dependent redistribution during apoptosis [file:mouse/Casp3/Casp3-uniprot.txt]. Genetic and biochemical studies in mice support the core catalytic assignment to cysteine-type endopeptidase or peptidase activity rather than broad generic binding terms [PMID:9512515; PMID:16469926].
Execution phase of apoptosis is the strongest core process assignment for Casp3. Caspase-3-deficient mouse cells and tissues show reduced or delayed apoptosis, impaired nuclear apoptotic changes, and resistance to several apoptotic stimuli, consistent with an obligate downstream effector role [PMID:9512515; PMID:10479688; PMID:16469926].
Positive regulation of apoptotic DNA fragmentation is also well supported as a mechanistic extension of the effector role because Casp3 activity is tightly linked to the nuclear changes and DNA degradation that follow apoptotic commitment PMID:9512515. Broader terms such as generic positive regulation of apoptotic process are usually correct but less precise than execution phase of apoptosis.
Some orthology-derived annotations are likely overextended. Mouse Casp3 may participate in specific inflammatory, neuronal, or disease contexts, but broad transfers to cytokine regulation, interleukin-18 signaling, amyloid-beta formation, pyroptotic inflammatory response, response to glucose, or cellular response to staurosporine do not summarize the core conserved activity of the gene and often represent downstream context rather than direct evolved function [file:mouse/Casp3/Casp3-uniprot.txt; PMID:24478350].
The neurotrophin TRK receptor signaling pathway transfer tied to PMID:23954828 appears especially weak for Casp3 itself: that paper is centered on Dok5 and TrkC survival signaling, with caspase-3 measured as a downstream apoptosis readout rather than as a dedicated Trk pathway component.
Casp3 is primarily a cytoplasmic or cytosolic effector protease, which is consistent with both UniProt and multiple mouse annotations [file:mouse/Casp3/Casp3-uniprot.txt]. The active enzyme is a heterotetramer, so the cellular component term caspase complex is consistent with the mature protease state [file:mouse/Casp3/Casp3-uniprot.txt].
Nuclear localization can occur in apoptotic contexts and is plausible as a non-core, context-dependent localization tied to substrate cleavage and nuclear apoptotic changes PMID:9512515. In contrast, terms such as death-inducing signaling complex or direct death receptor binding are not well supported as core Casp3 localizations or molecular functions for the mouse protein itself.
The safest ISO transfers are the ones that match the established effector-caspase identity of Casp3: cysteine-type endopeptidase activity, peptidase activity, cytoplasm/cytosol, proteolysis, apoptotic process, execution phase of apoptosis, and positive regulation of apoptotic DNA fragmentation. Context-specific neuronal or differentiation annotations may be kept as non-core when they align with mouse phenotypes, but they should not define the gene.
The least defensible ISO transfers are the overly generic or mechanistically indirect ones. Protease binding, protein-containing complex binding, death receptor binding, intracellular signal transduction, protein poly-ADP-ribosylation, and several stimulus-specific response terms do not capture Casp3's direct activity. Likewise, inflammatory and amyloid-related transfers appear to summarize specialized downstream settings rather than the core role of the gene.